GlassScriptPhysician profile
Kimberly L Brey
NPI 1639331374
$720.84
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $16.92 · 2022: $202 · 2023: $163 · 2024: $39.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $202.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $359.74 | 2019-2023 | Lo Loestrin Fe |
| Medtronic, INC. | $62.84 | 2022-2023 | Truclear |
| Axonics, INC. | $48.26 | 2023-2024 | Bulkamid |
| Hologic Sales and Service, LLC | $31.54 | 2019-2023 | Acessa Provu System, Novasure, Myosure Tissue Removal Device |
| Merck Sharp & Dohme LLC | $30.40 | 2019 | |
| Exeltis, USA INC. | $29.20 | 2022 | |
| Organon LLC | $25.88 | 2024 | |
| Coopersurgical, INC. | $21.58 | 2019 | |
| Sumitomo Pharma America, INC. | $19.56 | 2023 | Myfembree |
| Monaghan Medical Corporation | $18.23 | 2023 | Aerochamber |
| Therapeuticsmd, INC. | $17.70 | 2022 | |
| Becton, Dickinson and Company | $15.73 | 2023 | Bd Onclarity |
| Daiichi Sankyo INC. | $13.88 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.25 | 2022 | |
| Minerva Surgical, INC | $13.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Brey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.